BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp cut its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 12.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 393,834 shares of the company's stock after selling 56,862 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in Procter & Gamble were worth $68,212,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its stake in shares of Procter & Gamble by 19,030.8% in the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company's stock valued at $639,730,000 after acquiring an additional 3,674,286 shares in the last quarter. Wulff Hansen & CO. raised its holdings in Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company's stock valued at $606,230,000 after acquiring an additional 3,653,477 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at $301,950,000. AMF Tjanstepension AB grew its holdings in shares of Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company's stock worth $315,016,000 after purchasing an additional 1,466,115 shares in the last quarter. Finally, Icon Wealth Advisors LLC increased its position in shares of Procter & Gamble by 4,621.9% in the third quarter. Icon Wealth Advisors LLC now owns 1,285,923 shares of the company's stock worth $222,722,000 after purchasing an additional 1,258,690 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the company's stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares in the company, valued at $46,203,373.80. This represents a 2.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the business's stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 35,233 shares of company stock worth $6,024,234. 0.18% of the stock is owned by corporate insiders.
Analyst Ratings Changes
PG has been the topic of a number of analyst reports. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an "overweight" rating in a research note on Friday, November 22nd. JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research note on Thursday, September 19th. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. Hsbc Global Res upgraded Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $180.45.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble Stock Up 0.0 %
PG stock opened at $179.37 on Friday. The company has a market cap of $422.42 billion, a P/E ratio of 30.93, a price-to-earnings-growth ratio of 3.86 and a beta of 0.42. The stock's 50 day simple moving average is $170.48 and its 200 day simple moving average is $169.07. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analysts' expectations of $21.99 billion. During the same period last year, the company earned $1.83 earnings per share. The business's revenue was down .6% on a year-over-year basis. On average, research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.24%. Procter & Gamble's dividend payout ratio is presently 69.31%.
Procter & Gamble Profile
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report